Towers Watson & Co (TW) 123.00 $TW
Corporate Pension Plan Funding Levels Showed Little Change in 2015, Towers Watson Analysis Finds
BusinessWire - Mon Jan 04, 8:05AM CST
The pension funded status of the nation's largest corporate plan sponsors finished the year unchanged compared with the end of 2014, due in large part to a rise in interest rates mostly offset by a weak global stock market, according to a new analysis by global professional services company Towers Watson (NASDAQ:TW).
TW: 123.00 (-5.46)
Willis Group (WSH) Expands Globally with Gras Savoye Buy
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 10:10AM CST
Willis Group Holdings plc (WSH) recently acquired French insurance broker, Gras Savoye.
BRO: 37.87 (-0.13), WSH: 47.18 (-1.39), AJG: 50.05 (+0.06), TW: 123.00 (-5.46)
CRA International (CRAI) Aims at Healthy Organic Growth
Zacks Equity Research - Zacks Investment Research - Tue Dec 29, 3:15PM CST
On Dec 29, Zacks Investment Research updated the research report on management services provider CRA International Inc. (CRAI).
KRNT: 10.58 (-0.32), SERV: 37.67 (+0.11), CRAI: 27.30 (+0.57), TW: 123.00 (-5.46)
Willis Group's Cost-Cut Efforts Impress, High Expenses a Drag
Zacks Equity Research - Zacks Investment Research - Thu Dec 24, 10:00AM CST
On Dec 24, 2015, we issued an updated research report on global insurance broker Willis Group Holdings Public Limited Company (WSH).
VR: 50.94 (+0.22), BCRH: 17.68 (-0.01), WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Cintas Beats Q2 Earnings on Organic Growth, Revises Outlook
Zacks Equity Research - Zacks Investment Research - Tue Dec 22, 8:00AM CST
Cintas Corporation (CTAS) continued its bull run in fiscal 2016 by recording solid second-quarter results on the back of healthy top-line growth.
CBZ: 11.24 (+0.01), CTAS: 119.15 (+0.31), TW: 123.00 (-5.46), NCI: 19.82 (-0.04)
Employers Take Aim to Curb High Cost of Pharmacy Benefits
BusinessWire - Tue Dec 15, 8:05AM CST
With the availability of expensive new specialty drugs* and a rise in the use of compound drugs, employers are facing a rapid increase in prescription drug spend that makes it more difficult to control rising health care costs. In response, employers are taking specific action now and over the next three years to rein in prescription drug spending, according to experts at global professional services company Towers Watson (NASDAQ:TW).
TW: 123.00 (-5.46)
Pension Funds Benefit From Bank Stress Tests
BusinessWire - Mon Dec 14, 8:05AM CST
Institutional investors are exploiting the illiquid credit space vacated by banks facing stricter regulation and ongoing stress tests, according to global professional services company Towers Watson (NASDAQ: TW). The company's clients have allocated over $7 billion to illiquid credit investment strategies globally in the past five years, and it expects this to grow as the area remains largely untapped and compelling tailwinds remain. In new research entitled: Illiquid credit -- Playing the role of (good) bank, Towers Watson suggests there is still an early mover advantage for those investors willing to overcome the additional governance and complexity associated with successful investing in illiquid credit.
TW: 123.00 (-5.46)
Nearly Flat Growth for Commercial Insurance Prices in Third Quarter
BusinessWire - Mon Dec 14, 8:05AM CST
Commercial insurance prices were nearly flat (0.8% increase) in aggregate during the third quarter of 2015, continuing a trend of tempering increases that began in the first quarter of 2013, according to the latest Commercial Lines Insurance Pricing Survey (CLIPS) conducted by global professional services company Towers Watson (NASDAQ: TW). The survey compared prices charged on policies underwritten during the third quarter of 2015 to those charged for the same coverage during the same quarter of 2014.
TW: 123.00 (-5.46)
Driehaus Capital Management Reacts to Towers Watson Shareholder Approval of the Willis Group Holdings Transaction
PR Newswire - Fri Dec 11, 12:11PM CST
Driehaus Capital Management, a Chicago-based investment adviser of funds that own 1,515,814 shares of Towers Watson & Company (NASDAQ: TW), issued the following open letter to TW shareholders:
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Willis and Towers Watson Shareholders Approve Merger
GlobeNewswire - Fri Dec 11, 7:45AM CST
Shareholders Vote to Create Leading Global Advisory, Broking and Solutions Firm
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Surveys Reveal Disconnect Between Retirees and Employers Over Retirement Medical Benefits
BusinessWire - Thu Dec 10, 8:05AM CST
Surveys of retirees and employers reveal a significant gap between what retirees recalled they were told about their retirement medical benefits before they retired and what employers believe they communicated. While 43% of retirees surveyed said their employers took no steps at all to help them understand and manage the cost of retiree medical benefits before they retired, just 9% of employers acknowledged they offered no help.
TW: 123.00 (-5.46)
Willis Group Confirms Commitment to Existing Terms of Proposed Merger
GlobeNewswire - Wed Dec 09, 3:49PM CST
Terms are best and final offer
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
North American Employers Modernizing, Not Scrapping, Performance Management Process, Towers Watson Survey Finds
BusinessWire - Wed Dec 09, 8:10AM CST
Despite dissatisfaction with their performance management programs and attention-grabbing headlines, most North American employers have no intention of eliminating their use of performance ratings. Instead, many are making significant changes to fix the overall process, such as replacing annual performance review cycles with more frequent employee and manager interactions, applying a more future-oriented definition of performance and potential, and implementing new technology, according to a survey by global professional services company Towers Watson (NASDAQ: TW).
TW: 123.00 (-5.46)
Towers Watson Urges Stockholders to Vote FOR the Proposed Merger with Willis on December 11, 2015
BusinessWire - Mon Dec 07, 8:25AM CST
--Combination Expected to Create Approximately $4.7 Billion in Incremental Value and Over 40% Long-Term Earnings Cash Accretion for Stockholders
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Downgrade Alert for Towers Watson & Co (TW)
Comtex SmarTrend(R) - Mon Dec 07, 7:07AM CST
Towers Watson & Co (NYSE:TW) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $135.00 on volume of 534,000 shares, above average daily volume of 331,000. There is potential upside of 7.5% for shares of Towers Watson & Co based on a current price of $135.00 and an average consensus analyst price target of $145.09. The stock should discover initial support at its 200-day moving average (MA) of $128.64 and subsequent support at its 50-day MA of $125.74.
TW: 123.00 (-5.46)
Fitch: U.S. Insurance Brokers to See Modest 2016 Earnings Growth
BusinessWire - Thu Dec 03, 9:09AM CST
Revenues and earnings for U.S. insurance brokers are likely to modestly improve in 2016 relative to levels reported through nine months of 2015, according to Fitch Ratings' 2016 U.S. Insurance Broker Outlook report.
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
BUYINS.NET: MAR, CPSI, GPN, TW, MPX, ELS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 10:54PM CST
November 18, 2015
MPX: 8.97 (+0.01), GPN: 76.71 (+0.39), CPSI: 25.11 (-0.27), ELS: 79.55 (+0.69), MAR: 70.09 (-0.87), TW: 123.00 (-5.46)
Towers Watson Highlights Important Details Regarding Enhanced Terms of Proposed Merger with Willis
BusinessWire - Mon Nov 30, 8:20AM CST
--Total Implied Value Increased Approximately 8.6%
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Corporate Pension Plan Funding Levels Showed Little Change in 2015, Towers Watson Analysis Finds
BusinessWire - Mon Jan 04, 8:05AM CST
The pension funded status of the nation's largest corporate plan sponsors finished the year unchanged compared with the end of 2014, due in large part to a rise in interest rates mostly offset by a weak global stock market, according to a new analysis by global professional services company Towers Watson (NASDAQ:TW).
TW: 123.00 (-5.46)
Willis Group (WSH) Expands Globally with Gras Savoye Buy
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 10:10AM CST
Willis Group Holdings plc (WSH) recently acquired French insurance broker, Gras Savoye.
BRO: 37.87 (-0.13), WSH: 47.18 (-1.39), AJG: 50.05 (+0.06), TW: 123.00 (-5.46)
CRA International (CRAI) Aims at Healthy Organic Growth
Zacks Equity Research - Zacks Investment Research - Tue Dec 29, 3:15PM CST
On Dec 29, Zacks Investment Research updated the research report on management services provider CRA International Inc. (CRAI).
KRNT: 10.58 (-0.32), SERV: 37.67 (+0.11), CRAI: 27.30 (+0.57), TW: 123.00 (-5.46)
Willis Group's Cost-Cut Efforts Impress, High Expenses a Drag
Zacks Equity Research - Zacks Investment Research - Thu Dec 24, 10:00AM CST
On Dec 24, 2015, we issued an updated research report on global insurance broker Willis Group Holdings Public Limited Company (WSH).
VR: 50.94 (+0.22), BCRH: 17.68 (-0.01), WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Cintas Beats Q2 Earnings on Organic Growth, Revises Outlook
Zacks Equity Research - Zacks Investment Research - Tue Dec 22, 8:00AM CST
Cintas Corporation (CTAS) continued its bull run in fiscal 2016 by recording solid second-quarter results on the back of healthy top-line growth.
CBZ: 11.24 (+0.01), CTAS: 119.15 (+0.31), TW: 123.00 (-5.46), NCI: 19.82 (-0.04)
Employers Take Aim to Curb High Cost of Pharmacy Benefits
BusinessWire - Tue Dec 15, 8:05AM CST
With the availability of expensive new specialty drugs* and a rise in the use of compound drugs, employers are facing a rapid increase in prescription drug spend that makes it more difficult to control rising health care costs. In response, employers are taking specific action now and over the next three years to rein in prescription drug spending, according to experts at global professional services company Towers Watson (NASDAQ:TW).
TW: 123.00 (-5.46)
Pension Funds Benefit From Bank Stress Tests
BusinessWire - Mon Dec 14, 8:05AM CST
Institutional investors are exploiting the illiquid credit space vacated by banks facing stricter regulation and ongoing stress tests, according to global professional services company Towers Watson (NASDAQ: TW). The company's clients have allocated over $7 billion to illiquid credit investment strategies globally in the past five years, and it expects this to grow as the area remains largely untapped and compelling tailwinds remain. In new research entitled: Illiquid credit -- Playing the role of (good) bank, Towers Watson suggests there is still an early mover advantage for those investors willing to overcome the additional governance and complexity associated with successful investing in illiquid credit.
TW: 123.00 (-5.46)
Nearly Flat Growth for Commercial Insurance Prices in Third Quarter
BusinessWire - Mon Dec 14, 8:05AM CST
Commercial insurance prices were nearly flat (0.8% increase) in aggregate during the third quarter of 2015, continuing a trend of tempering increases that began in the first quarter of 2013, according to the latest Commercial Lines Insurance Pricing Survey (CLIPS) conducted by global professional services company Towers Watson (NASDAQ: TW). The survey compared prices charged on policies underwritten during the third quarter of 2015 to those charged for the same coverage during the same quarter of 2014.
TW: 123.00 (-5.46)
Driehaus Capital Management Reacts to Towers Watson Shareholder Approval of the Willis Group Holdings Transaction
PR Newswire - Fri Dec 11, 12:11PM CST
Driehaus Capital Management, a Chicago-based investment adviser of funds that own 1,515,814 shares of Towers Watson & Company (NASDAQ: TW), issued the following open letter to TW shareholders:
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Willis and Towers Watson Shareholders Approve Merger
GlobeNewswire - Fri Dec 11, 7:45AM CST
Shareholders Vote to Create Leading Global Advisory, Broking and Solutions Firm
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Surveys Reveal Disconnect Between Retirees and Employers Over Retirement Medical Benefits
BusinessWire - Thu Dec 10, 8:05AM CST
Surveys of retirees and employers reveal a significant gap between what retirees recalled they were told about their retirement medical benefits before they retired and what employers believe they communicated. While 43% of retirees surveyed said their employers took no steps at all to help them understand and manage the cost of retiree medical benefits before they retired, just 9% of employers acknowledged they offered no help.
TW: 123.00 (-5.46)
Willis Group Confirms Commitment to Existing Terms of Proposed Merger
GlobeNewswire - Wed Dec 09, 3:49PM CST
Terms are best and final offer
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
North American Employers Modernizing, Not Scrapping, Performance Management Process, Towers Watson Survey Finds
BusinessWire - Wed Dec 09, 8:10AM CST
Despite dissatisfaction with their performance management programs and attention-grabbing headlines, most North American employers have no intention of eliminating their use of performance ratings. Instead, many are making significant changes to fix the overall process, such as replacing annual performance review cycles with more frequent employee and manager interactions, applying a more future-oriented definition of performance and potential, and implementing new technology, according to a survey by global professional services company Towers Watson (NASDAQ: TW).
TW: 123.00 (-5.46)
Towers Watson Urges Stockholders to Vote FOR the Proposed Merger with Willis on December 11, 2015
BusinessWire - Mon Dec 07, 8:25AM CST
--Combination Expected to Create Approximately $4.7 Billion in Incremental Value and Over 40% Long-Term Earnings Cash Accretion for Stockholders
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
Downgrade Alert for Towers Watson & Co (TW)
Comtex SmarTrend(R) - Mon Dec 07, 7:07AM CST
Towers Watson & Co (NYSE:TW) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $135.00 on volume of 534,000 shares, above average daily volume of 331,000. There is potential upside of 7.5% for shares of Towers Watson & Co based on a current price of $135.00 and an average consensus analyst price target of $145.09. The stock should discover initial support at its 200-day moving average (MA) of $128.64 and subsequent support at its 50-day MA of $125.74.
TW: 123.00 (-5.46)
Fitch: U.S. Insurance Brokers to See Modest 2016 Earnings Growth
BusinessWire - Thu Dec 03, 9:09AM CST
Revenues and earnings for U.S. insurance brokers are likely to modestly improve in 2016 relative to levels reported through nine months of 2015, according to Fitch Ratings' 2016 U.S. Insurance Broker Outlook report.
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
BUYINS.NET: MAR, CPSI, GPN, TW, MPX, ELS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 10:54PM CST
November 18, 2015
MPX: 8.97 (+0.01), GPN: 76.71 (+0.39), CPSI: 25.11 (-0.27), ELS: 79.55 (+0.69), MAR: 70.09 (-0.87), TW: 123.00 (-5.46)
Towers Watson Highlights Important Details Regarding Enhanced Terms of Proposed Merger with Willis
BusinessWire - Mon Nov 30, 8:20AM CST
--Total Implied Value Increased Approximately 8.6%
WSH: 47.18 (-1.39), TW: 123.00 (-5.46)
